Company Filing History:
1 out of 832,843 Years Active: 2004
Title: Ralf Pettersson: Innovator in Angiogenic Activity Stimulation
Introduction
Ralf Pettersson is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical technology, particularly in the stimulation of angiogenic activity. His innovative approach has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Ralf Pettersson holds a patent for "In vivo stimulation of angiogenic activity." This patent describes a method where angiogenesis is stimulated by introducing two replication-deficient adenovirus vectors to the endothelial cells or in proximity to these cells within an organism. The first vector encodes VEGF-B or a fragment or conservative substitution thereof, while the second vector encodes VEGF-A or VEGF-C, or fragments or conservative substitutions thereof. He has 1 patent to his name.
Career Highlights
Throughout his career, Ralf has focused on advancing medical technologies that enhance vascular growth and repair. His work has garnered attention for its innovative approach to treating conditions that require improved blood flow and tissue regeneration.
Collaborations
Ralf Pettersson has collaborated with esteemed colleagues such as Berndt Enholm and Didier Branellec. These partnerships have contributed to the development and refinement of his innovative techniques in angiogenesis.
Conclusion
Ralf Pettersson's contributions to the field of angiogenic activity stimulation highlight his role as a key innovator in medical technology. His patent and collaborative efforts reflect a commitment to advancing therapeutic solutions for critical health challenges.